Table 1 Clinical characteristic of the study cohort
From: Radiological semantics discriminate clinically significant grade prostate cancer
a. Biopsy Histology characterization | |||
| Â | Category | Total Number Biopsies: 167 (103 Patients) | Over-read Cohort (random): (40 Biopsy, 34 Patients) |
1 | Benign | 77 (53 patients) | 19 |
2 | Gleason (3 + 3): 6 | 33 (28 patients) | 8 |
3 | Gleason (3 + 4 or 4 + 3):7 | 45 (35 patients) | 11 |
4 | Gleason: 8 or 9 | 12 (9 patients) | 2 |
b. Patient characteristics of the study cohorts. | |||
| Â | Category | Total Number (103 Patients) | Over-read Cohort: (random) (32Patients) |
1 | Age (Median, range) | 67 [44, 83] | 65.53, [52,76] |
2 | Race | White:98, Black:2, Others:3 | White: 30, Others: 2. |
3 | Disease Grade | T1a:23,T1b:2,T1C:59,T2A:3, T2C:1,T3A: 3, T3B:1: Benign:15 | T1:1, T1C: 21, T2A: 2, T3a: 1, Benign/Others: 7 |
4 | Gleason Grade | GS≥6: 90, (=6,33; =7,45; =8,4; =9,8) Benign: 77 | GS ≥ 6: 19 (=6:6,=7,10,=8,2,=9,1) Benign: 13 . |
5 | PSA (ng/ml) | 7.56, [0.64, 44.7] | 6.63 (6.59), [2.39,15.95] |
6 | Tumor Target Zone (Peripheral /Transition) | Central: 56 Peripheral:102 Middle: 9 | Central: 16 Peripheral: 23 Middle: 1 |